News
Eli Lilly and Company (NYSE:LLY) is one of the Good Stocks to Invest in Now. On August 7, Eli Lilly and Company (NYSE:LLY) announced positive results from its Phase 3 ATTAIN-1 trial of Orforglipron, ...
Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...
1h
Zacks Investment Research on MSNLilly (LLY) Reliance on International Sales: What Investors Need to KnowDid you analyze how Eli Lilly (LLY) fared in its international operations for the quarter ending June 2025? Given the widespread global presence of this drugmaker, scrutinizing the trends in ...
1h
Zacks Investment Research on MSNEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowEli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Eli Lilly and Company (NYSE: LLY) is one of the top most profitable NYSE stocks to buy now. On August 7, Leerink downgraded ...
Glucagon for Injection USP, 1mg/vial packaged in an emergency kit is bioequivalent to Glucagon for Injection, 1 mg/vial of Eli Lilly and Company. Glucagon is indicated for the treatment of severe ...
Patients with psoriasis have significantly more difficulty sleeping, particularly in new environments, than matched ...
An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...
A mum who admitted that she has illegally put her 13-year-old child on Mounjaro weight loss jabs has spoken out on why she ...
New York hospitals that get discounted drugs through a controversial federal program are gearing up for a new pilot that they ...
China’s drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...
Lupin introduces generic Glucagon for Injection USP in the US market. Bioequivalent to Eli Lilly's, used for hypoglycemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results